By: Joey Garcia | January 27, 2025 | 7 min. read | Share Article Summary Results from the HIV Organ Policy Equity (HOPE) study shows kidney transplants from HIV-positive donors to HIV-positive recipients are just as safe and effective as those from HIV-negative donors. The HOPE study has examined the risks and benefits of using kidneys … Read more
The Shkreli Awards, an annual event hosted by the Lown Institute, have become a biting critique of the American healthcare system. Named after the infamous “pharma bro” Martin shkreli, these awards spotlight the most egregious examples of profiteering and dysfunction in healthcare.This year’s ceremony, the eighth edition, continued to shine a light on the systemic … Read more
The efficacy and tolerability of the 2-drug regimen of dolutegravir (DTG) and lamivudine (3TC) in individuals living with HIV was evaluated in a review published in Infectious Diseases and Therapy,1 confirming the results seen in phase 3 trials of the treatment. HIV causes immunosuppression because the virus attacks cells that usually fight infections. People living … Read more
Researchers at the University of Massachusetts Amherst have quantified the impacts of a constellation of social factors on the spread of HIV. Their study, published in Health Care Management Science, found that a hypothetical 100% effective intervention addressing barriers to HIV treatment and care from depression, homelessness, individual and neighborhood poverty, education disparities, lack of … Read more
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally, posing a particularly significant threat to people with HIV (PWH). To address this, CVD prevention plans rely on prediction models like atherosclerotic cardiovascular disease (ASCVD) risk scores to estimate the risk of heart disease. However, previous studies have called into question whether these … Read more
Doxycycline postexposure prophylaxis (doxyPEP) has the potential to substantially reduce real-world population-level incidence of sexually transmitted infections (STIs), a study in JAMA Internal Medicine suggested. This conclusion was reached by Stephanie E. Cohen, MD, medical director of the San Francisco City Clinic, Department of Public Health in San Francisco, and colleagues after examining STI trends … Read more
Every week, 4000 young cisgender women aged 15-24 years contract HIV globally, according to 2023 data. Infections in this age group accounted for 44% of the new global infections that year, highlighting the vulnerability of this population to AIDS. Despite these alarming figures, awareness of and access to preventive measures, such as pre-exposure prophylaxis (PrEP) … Read more
Extreme weather events linked to climate change exacerbate health inequities for people living with HIV, impacting prevention, care, and treatment outcomes, particularly in vulnerable regions like sub-Saharan Africa. Study: Climate change and extreme weather events and linkages with HIV outcomes: recent advances and ways forward. Image Credit: Arctic_photo / Shutterstock.com A recent review published in Current … Read more
Promising new drugs to prevent and treat HIV have the potential to transform the response to the disease. But getting these drugs to those who need it most will be critical, says Beatriz Grinsztejn, president of the International AIDS Society. Grinsztejn is the first Latin American to head the IAS, which has been advocating since … Read more
Understanding U=U: A Breakthrough in HIV Prevention and Stigma Reduction Table of Contents Understanding U=U: A Breakthrough in HIV Prevention and Stigma Reduction The Science Behind U=U Breaking Down the Stigma Progress in Prevention and Treatment What U=U Means for Daily Life Key Takeaways: U=U at a Glance A Call to Action U=U: … Read more